Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation
Litton, Jennifer K, Rugo, Hope S, Ettl, Johannes, Hurvitz, Sara A, Gonçalves, Anthony, Lee, Kyung-Hun, Fehrenbacher, Louis, Yerushalmi, Rinat, Mina, Lida A, Martin, Miguel, Roché, Henri, Im, Young-Hyuck, Quek, Ruben G.W, Markova, Denka, Tudor, Iulia C, Hannah, Alison L, Eiermann, Wolfgang, Blum, Joanne L
Published in The New England journal of medicine (23.08.2018)
Published in The New England journal of medicine (23.08.2018)
Get full text
Journal Article
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial
Tripathy, Debu, Im, Seock-Ah, Colleoni, Marco, Franke, Fabio, Bardia, Aditya, Harbeck, Nadia, Hurvitz, Sara A, Chow, Louis, Sohn, Joohyuk, Lee, Keun Seok, Campos-Gomez, Saul, Villanueva Vazquez, Rafael, Jung, Kyung Hae, Babu, K Govind, Wheatley-Price, Paul, De Laurentiis, Michelino, Im, Young-Hyuck, Kuemmel, Sherko, El-Saghir, Nagi, Liu, Mei-Ching, Carlson, Gary, Hughes, Gareth, Diaz-Padilla, Ivan, Germa, Caroline, Hirawat, Samit, Lu, Yen-Shen
Published in The lancet oncology (01.07.2018)
Published in The lancet oncology (01.07.2018)
Get full text
Journal Article
Cytokine profiling in serum-derived exosomes isolated by different methods
Jung, Hae Hyun, Kim, Ji-Yeon, Lim, Ji Eun, Im, Young-Hyuck
Published in Scientific reports (21.08.2020)
Published in Scientific reports (21.08.2020)
Get full text
Journal Article
Trastuzumab emtansine with or without pertuzumab versus trastuzumab with taxane for human epidermal growth factor receptor 2–positive advanced breast cancer: Final results from MARIANNE
Perez, Edith A., Barrios, Carlos, Eiermann, Wolfgang, Toi, Masakazu, Im, Young‐Hyuck, Conte, Pierfranco, Martin, Miguel, Pienkowski, Tadeusz, Pivot, Xavier B., Burris, Howard A., Petersen, Jennifer A., De Haas, Sanne, Hoersch, Silke, Patre, Monika, Ellis, Paul Anthony
Published in Cancer (15.11.2019)
Published in Cancer (15.11.2019)
Get full text
Journal Article
Multimodal deep learning models for the prediction of pathologic response to neoadjuvant chemotherapy in breast cancer
Joo, Sunghoon, Ko, Eun Sook, Kwon, Soonhwan, Jeon, Eunjoo, Jung, Hyungsik, Kim, Ji-Yeon, Chung, Myung Jin, Im, Young-Hyuck
Published in Scientific reports (22.09.2021)
Published in Scientific reports (22.09.2021)
Get full text
Journal Article
5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial
Gianni, Luca, Prof, Pienkowski, Tadeusz, Prof, Im, Young-Hyuck, Prof, Tseng, Ling-Ming, MD, Liu, Mei-Ching, MD, Lluch, Ana, MD, Starosławska, Elżbieta, Prof, de la Haba-Rodriguez, Juan, MD, Im, Seock-Ah, Prof, Pedrini, Jose Luiz, MD, Poirier, Brigitte, MD, Morandi, Paolo, MD, Semiglazov, Vladimir, Prof, Srimuninnimit, Vichien, Prof, Bianchi, Giulia Valeria, MD, Magazzù, Domenico, PhD, McNally, Virginia, PhD, Douthwaite, Hannah, MSc, Ross, Graham, FFPM, Valagussa, Pinuccia, BS
Published in The lancet oncology (01.06.2016)
Published in The lancet oncology (01.06.2016)
Get full text
Journal Article
A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients
Hwang, Hye Won, Jung, Hera, Hyeon, Jiyeon, Park, Yeon Hee, Ahn, Jin Seok, Im, Young-Hyuck, Nam, Seok Jin, Kim, Seok Won, Lee, Jeong Eon, Yu, Jong-Han, Lee, Se Kyung, Choi, Misun, Cho, Soo Youn, Cho, Eun Yoon
Published in Breast cancer research and treatment (01.01.2019)
Published in Breast cancer research and treatment (01.01.2019)
Get full text
Journal Article
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
Gianni, Luca, Dr, Pienkowski, Tadeusz, Prof, Im, Young-Hyuck, Prof, Roman, Laslo, MD, Tseng, Ling-Ming, MD, Liu, Mei-Ching, MD, Lluch, Ana, MD, Staroslawska, Elżbieta, Prof, de la Haba-Rodriguez, Juan, MD, Im, Seock-Ah, Prof, Pedrini, Jose Luiz, MD, Poirier, Brigitte, MD, Morandi, Paolo, MD, Semiglazov, Vladimir, Prof, Srimuninnimit, Vichien, Prof, Bianchi, Giulia, MD, Szado, Tania, PhD, Ratnayake, Jayantha, BSc, Ross, Graham, MD, Valagussa, Pinuccia, BS
Published in The lancet oncology (2012)
Published in The lancet oncology (2012)
Get full text
Journal Article
Abemaciclib plus fulvestrant in East Asian women with HR+, HER2− advanced breast cancer: Overall survival from MONARCH 2
Toi, Masakazu, Huang, Chiun‐Sheng, Im, Young‐Hyuck, Sohn, Joohyuk, Zhang, Wei, Sakaguchi, Sachi, Haddad, Nadine, Hal, Gertjan, Sledge, George W.
Published in Cancer science (01.01.2023)
Published in Cancer science (01.01.2023)
Get full text
Journal Article
Impact of chemotherapy-induced alopecia distress on body image, psychosocial well-being, and depression in breast cancer patients
Choi, Eun Kyung, Kim, Im-Ryung, Chang, Oliver, Kang, Danbee, Nam, Seok-Jin, Lee, Jeong Eon, Lee, Se Kyung, Im, Young-Hyuck, Park, Yeon Hee, Yang, Jung-Hyun, Cho, Juhee
Published in Psycho-oncology (Chichester, England) (01.10.2014)
Published in Psycho-oncology (Chichester, England) (01.10.2014)
Get full text
Journal Article
Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures
Kan, Zhengyan, Ding, Ying, Kim, Jinho, Jung, Hae Hyun, Chung, Woosung, Lal, Samir, Cho, Soonweng, Fernandez-Banet, Julio, Lee, Se Kyung, Kim, Seok Won, Lee, Jeong Eon, Choi, Yoon-La, Deng, Shibing, Kim, Ji-Yeon, Ahn, Jin Seok, Sha, Ying, Mu, Xinmeng Jasmine, Nam, Jae-Yong, Im, Young-Hyuck, Lee, Soohyeon, Park, Woong-Yang, Nam, Seok Jin, Park, Yeon Hee
Published in Nature communications (30.04.2018)
Published in Nature communications (30.04.2018)
Get full text
Journal Article
A phase II trial of the pan‐HER inhibitor poziotinib, in patients with HER2‐positive metastatic breast cancer who had received at least two prior HER2‐directed regimens: results of the NOV120101‐203 trial
Park, Yeon Hee, Lee, Kyung‐Hun, Sohn, Joo Hyuk, Lee, Keun Seok, Jung, Kyung Hae, Kim, Jee‐Hyun, Lee, Ki Hyeong, Ahn, Jin Seok, Kim, Tae‐Yong, Kim, Gun Min, Park, In Hae, Kim, Sung‐Bae, Kim, Se Hyun, Han, Hye Sook, Im, Young‐Hyuck, Ahn, Jin‐Hee, Kim, Jung‐Yong, Kang, Jahoon, Im, Seock‐Ah
Published in International journal of cancer (15.12.2018)
Published in International journal of cancer (15.12.2018)
Get full text
Journal Article
Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial
Cameron, David, Prof, Brown, Julia, Prof, Dent, Rebecca, MD, Jackisch, Christian, MD, Mackey, John, Prof, Pivot, Xavier, MD, Steger, Guenther G, Prof, Suter, Thomas M, Prof, Toi, Masakazu, Prof, Parmar, Mahesh, DPhil, Laeufle, Rita, MD, Im, Young-Hyuck, MD, Romieu, Gilles, MD, Harvey, Vernon, MD, Lipatov, Oleg, MD, Pienkowski, Tadeusz, MD, Cottu, Paul, MD, Chan, Arlene, Prof, Im, Seock-Ah, Prof, Hall, Peter S, PhD, Bubuteishvili-Pacaud, Lida, MD, Henschel, Volkmar, PhD, Deurloo, Regula J, PhD, Pallaud, Celine, PhD, Bell, Richard, Prof
Published in The lancet oncology (01.09.2013)
Published in The lancet oncology (01.09.2013)
Get full text
Journal Article
Prevalence and detection of low-allele-fraction variants in clinical cancer samples
Shin, Hyun-Tae, Choi, Yoon-La, Yun, Jae Won, Kim, Nayoung K. D., Kim, Sook-Young, Jeon, Hyo Jeong, Nam, Jae-Yong, Lee, Chung, Ryu, Daeun, Kim, Sang Cheol, Park, Kyunghee, Lee, Eunjin, Bae, Joon Seol, Son, Dae Soon, Joung, Je-Gun, Lee, Jeeyun, Kim, Seung Tae, Ahn, Myung-Ju, Lee, Se-Hoon, Ahn, Jin Seok, Lee, Woo Yong, Oh, Bo Young, Park, Yeon Hee, Lee, Jeong Eon, Lee, Kwang Hyuk, Kim, Hee Cheol, Kim, Kyoung-Mee, Im, Young-Hyuck, Park, Keunchil, Park, Peter J., Park, Woong-Yang
Published in Nature communications (09.11.2017)
Published in Nature communications (09.11.2017)
Get full text
Journal Article
TP53 mutations predict poor response to immunotherapy in patients with metastatic solid tumors
Kim, Ji‐Yeon, Jung, Jaeyun, Kim, Kyoung‐Mee, Lee, Jeeyun, Im, Young‐Hyuck
Published in Cancer medicine (Malden, MA) (01.06.2023)
Published in Cancer medicine (Malden, MA) (01.06.2023)
Get full text
Journal Article
Intratumor heterogeneity inferred from targeted deep sequencing as a prognostic indicator
Oh, Bo Young, Shin, Hyun-Tae, Yun, Jae Won, Kim, Kyu-Tae, Kim, Jinho, Bae, Joon Seol, Cho, Yong Beom, Lee, Woo Yong, Yun, Seong Hyeon, Park, Yoon Ah, Park, Yeon Hee, Im, Young-Hyuck, Lee, Jeeyun, Joung, Je-Gun, Kim, Hee Cheol, Park, Woong-Yang
Published in Scientific reports (14.03.2019)
Published in Scientific reports (14.03.2019)
Get full text
Journal Article
Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial
Park, Yeon Hee, Kim, Tae-Yong, Kim, Gun Min, Kang, Seok Yun, Park, In Hae, Kim, Jee Hyun, Lee, Kyoung Eun, Ahn, Hee Kyung, Lee, Moon Hee, Kim, Hee-Jun, Kim, Han Jo, Lee, Jong In, Koh, Su-Jin, Kim, Ji-Yeon, Lee, Kyung-Hun, Sohn, Joohyuk, Kim, Sung-Bae, Ahn, Jin-Seok, Im, Young-Hyuck, Jung, Kyung Hae, Im, Seock-Ah, Ahn, HK, Cho, EK, Park, IH, Lee, KS, Sim, SS, Hong, SJ, Chang, MH, Kim, JH, Kim, YJ, Kim, SH, Suh, KJ, Park, YH, Park, WY, Choi, YL, Yu, JH, Im, YH, Ahn, JS, Hur, JY, Park, SH, Kim, JY, Nam, SJ, Lee, JE, Kim, SW, Lee, SK, Im, SA, Kim, MS, Kim, TY, Oh, DY, Lee, KH, Lee, DW, Kim, HJ, Jung, KH, Kim, SB, Ahn, JH, Kim, JE, Jung, JH, Kang, SY, Ahn, MS, Choi, YW, Kim, GM, Sohn, JH, Kim, MH, Koh, SJ, Cheon, JK, Lee, JI, Lim, ST, Hyun, SY, Lee, KE, Lee, MH, Cho, JH, Lim, JH
Published in The lancet oncology (01.12.2019)
Published in The lancet oncology (01.12.2019)
Get full text
Journal Article
ER+, HER2- advanced breast cancer treated with taselisib and fulvestrant: genomic landscape and associated clinical outcomes
Chen, Jessica W, Jacot, William, Cortés, Javier, Krop, Ian E, Dent, Susan, Harbeck, Nadia, De Laurentiis, Michelino, Diéras, Véronique, Im, Young-Hyuck, Stout, Thomas J, Schimmoller, Frauke, Savage, Heidi M, Hutchinson, Katherine E, Wilson, Timothy R
Published in Molecular oncology (01.10.2023)
Published in Molecular oncology (01.10.2023)
Get full text
Journal Article
Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer
Bianchini, Giampaolo, Kiermaier, Astrid, Bianchi, Giulia Valeria, Im, Young-Hyuck, Pienkowski, Tadeusz, Liu, Mei-Ching, Tseng, Ling-Ming, Dowsett, Mitch, Zabaglo, Lila, Kirk, Sarah, Szado, Tania, Eng-Wong, Jennifer, Amler, Lukas C, Valagussa, Pinuccia, Gianni, Luca
Published in Breast cancer research : BCR (09.02.2017)
Published in Breast cancer research : BCR (09.02.2017)
Get full text
Journal Article